{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:58:54Z","timestamp":1787061534042,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:00:00Z","timestamp":1792886400000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1625735"],"award-info":[{"award-number":["CHE-1625735"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000904","name":"The Bradley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001166","name":"Richard and Ethel Herzfeld Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108449","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:20:10Z","timestamp":1761146410000},"page":"108449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates"],"prefix":"10.1016","volume":"249","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2908-3272","authenticated-orcid":false,"given":"Ethan T.","family":"Kowalczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8905-9240","authenticated-orcid":false,"given":"Kayode M.","family":"Medubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-4225","authenticated-orcid":false,"given":"Mubaraq A.","family":"Toriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Haasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8812-8768","authenticated-orcid":false,"given":"Makena R.","family":"Vesperman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene T.","family":"Yocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Emala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1411-1572","authenticated-orcid":false,"given":"Leggy A.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108449_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1183\/13993003.00853-2015","article-title":"A summary of the new GINA strategy: a roadmap to asthma control","volume":"46","author":"Reddel","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108449_bib2","first-page":"531","article-title":"Asthma Management: updated Guidelines from the national heart, lung, and Blood Institute","volume":"104","author":"Raymond","year":"2021","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.rmed.2025.108449_bib3","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.molpharmaceut.6b00159","article-title":"Development of GABAA receptor subtype-selective imidazobenzodiazepines as novel asthma treatments","volume":"13","author":"Forkuo","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.rmed.2025.108449_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejmech.2016.11.045","article-title":"Optimization of substituted imidazobenzodiazepines as novel asthma treatments","volume":"126","author":"Jahan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.rmed.2025.108449_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1152\/japplphysiol.91314.2008","article-title":"The GABAA agonist muscimol attenuates induced airway constriction in Guinea pigs in vivo","volume":"106","author":"Gleason","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2025.108449_bib6","doi-asserted-by":"crossref","first-page":"L931","DOI":"10.1152\/ajplung.00107.2014","article-title":"Selective targeting of the alpha5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling","volume":"308","author":"Gallos","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2025.108449_bib7","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acs.molpharmaceut.7b01013","article-title":"A novel orally available asthma drug candidate that reduces smooth muscle constriction and inflammation by targeting GABA(A) receptors in the lung","volume":"15","author":"Forkuo","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.rmed.2025.108449_bib8","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1021\/acs.molpharmaceut.7b00183","article-title":"Alleviation of multiple asthmatic pathologic features with orally available and subtype selective GABA(A) receptor modulators","volume":"14","author":"Forkuo","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.rmed.2025.108449_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ddr.21926","article-title":"Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer","volume":"83","author":"Rashid Roni","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.rmed.2025.108449_bib10","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1021\/acs.jmedchem.3c00647","article-title":"Design, synthesis, and biological evaluation of novel Spiro imidazobenzodiazepines to identify improved inhaled bronchodilators","volume":"66","author":"Webb","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.rmed.2025.108449_bib11","doi-asserted-by":"crossref","first-page":"L385","DOI":"10.1152\/ajplung.00356.2018","article-title":"A novel GABA(A) receptor ligand MIDD0301 with limited blood-brain barrier penetration relaxes airway smooth muscle ex vivo and in vivo","volume":"316","author":"Yocum","year":"2019","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2025.108449_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acsptsci.1c00238","article-title":"Development of Inhaled GABA(A) receptor modulators to improve airway function in bronchoconstrictive disorders","volume":"5","author":"Zahn","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.rmed.2025.108449_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1165\/rcmb.2022-0084OC","article-title":"Imidazobenzodiazepine PI320 relaxes Mouse Peripheral airways by inhibiting calcium mobilization","volume":"67","author":"Perez-Zoghbi","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.rmed.2025.108449_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.npp.1301403","article-title":"Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?","volume":"33","author":"Savic","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.rmed.2025.108449_bib15","article-title":"A structure-activity relationship comparison of imidazodiazepines binding at Kappa, Mu, and Delta opioid receptors and the GABA(A) receptor","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.rmed.2025.108449_bib16","first-page":"77","volume":"16","author":"He","year":"1999","journal-title":"Drug Des. Discov."},{"key":"10.1016\/j.rmed.2025.108449_bib17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acsptsci.0c00180","article-title":"Nebulized MIDD0301 reduces airway hyperresponsiveness in moderate and severe murine asthma models","volume":"3","author":"Zahn","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.rmed.2025.108449_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1021\/acs.oprd.0c00200","article-title":"Improved scale-up synthesis and purification of clinical asthma candidate MIDD0301","volume":"24","author":"Knutson","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.rmed.2025.108449_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.rmed.2025.108449_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125005128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125005128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:03:06Z","timestamp":1763690586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125005128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":20,"alternative-id":["S0954611125005128"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108449","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108449"}}